home2023-05-10T10:55:26+02:00

biomarkers for more stability in life

our purpose:
precision
medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious aging-related illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

TAmiRNA - stability for live

our technology:
microRNA
signatures

mircoRNA_signatures

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA levels and clinical parameters.

TAmiRNA - stability for live

our focus:
age-associated
diseases

age_associated_diseases

TAmiRNA is actively involved in R&D projects in osteoporosis (OP), cardio-vascular disease (CVD), liver disease and aging. OP and CVD are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.

TAmiRNA - stability for live

biomarkers for more stability in life

our purpose:
precision
medicine

discovery_and_validation_of_microRNA_biomarkers

TamiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious aging-related illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

our technology:
microRNA
signatures

mircoRNA_signatures

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA levels and clinical parameters.

our focus:
age-associated
diseases

TAmiRNA is actively involved in R&D projects in osteoporosis (OP), cardio-vascular disease (CVD), liver disease and aging. OP and CVD are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our services

microRNA services

services

Serum, plasma, urine, saliva, exosomes, cells, and tissues … We provide solutions for your biomarker discovery and validation needs in any biological matrix.

TAmiRNA - the power of microRNA biomarkers

Kit services

Send us your samples to obtain results for osteomiR®, thrombomiR® or toxomiR® biomarkers by taking advantage of our in-house services.

TAmiRNA - the power of microRNA biomarkers
Click_here_for_your_personalized_microRNA_service_offer

our services

microRNA services

services

Serum, plasma, urine, saliva, exosomes, cells, and tissues … We provide solutions for your biomarker discovery and validation needs.

TAmiRNA - the power of microRNA biomarkers

One-Stop-Shop

Obtain results for osteomiR, thrombomiR,and toxomiR biomarkers in your samples by taking advantage of our inhouseservices.

TAmiRNA - the power of microRNA biomarkers
TAmiRNA - stability for live

latest news

Celebrating the Nobel Prize in Physiology or Medicine 2024!

By |October 7th, 2024|Categories: biomarker, biomarkers, hepatomiR kit, microRNAs|Tags: , , |

Congratulations to Victor Ambros and Gary Ruvkun, this year’s Nobel Laureates, for their pioneering discovery of microRNAs—tiny but powerful molecules that regulate gene expression and have reshaped our understanding [...]

TAmiRNA at the GSEV 2024 Scientific Conference

By |September 27th, 2024|Categories: biomarker, biomarkers, exosomes, extracellular vesicle, Illumina NewSeq2000, microRNAs, miND, NGS, small RNA-sequencing|Tags: , , , , , , , |

We are thrilled to announce that TAmiRNA will contribute a poster at the upcoming German Society for Extracellular Vesicles (GSEV) Autumn Meeting 2024, presenting our recent advancements in the [...]

Comments Off on TAmiRNA at the GSEV 2024 Scientific Conference

Eager to lern more about neuron-derived extracellular vesicles as predictive biomarkers

By |September 18th, 2024|Categories: biomarker, biomarkers, exosomes, microRNA services, microRNAs, miND spike ins, NGS, sequencing, smallRNA|Tags: , , , , , , |

A new study from the University of Trieste explores the potential of microRNA (miRNA) profiles in neuron-derived extracellular vesicles (NDEVs) as predictive biomarkers for adverse drug reactions (ADRs) in [...]

Comments Off on Eager to lern more about neuron-derived extracellular vesicles as predictive biomarkers

Celebrating the Nobel Prize in Physiology or Medicine 2024!

By |October 7th, 2024|Categories: biomarker, biomarkers, hepatomiR kit, microRNAs|Tags: , , |

Congratulations to Victor Ambros and Gary Ruvkun, this year’s Nobel Laureates, for their pioneering discovery of microRNAs—tiny but powerful molecules that regulate gene expression and have reshaped our understanding of biology, aging, [...]

TAmiRNA at the GSEV 2024 Scientific Conference

By |September 27th, 2024|Categories: biomarker, biomarkers, exosomes, extracellular vesicle, Illumina NewSeq2000, microRNAs, miND, NGS, small RNA-sequencing|Tags: , , , , , , , |

We are thrilled to announce that TAmiRNA will contribute a poster at the upcoming German Society for Extracellular Vesicles (GSEV) Autumn Meeting 2024, presenting our recent advancements in the biodistribution of extracellular [...]

Comments Off on TAmiRNA at the GSEV 2024 Scientific Conference

Eager to lern more about neuron-derived extracellular vesicles as predictive biomarkers

By |September 18th, 2024|Categories: biomarker, biomarkers, exosomes, microRNA services, microRNAs, miND spike ins, NGS, sequencing, smallRNA|Tags: , , , , , , |

A new study from the University of Trieste explores the potential of microRNA (miRNA) profiles in neuron-derived extracellular vesicles (NDEVs) as predictive biomarkers for adverse drug reactions (ADRs) in children receiving ketamine. [...]

Comments Off on Eager to lern more about neuron-derived extracellular vesicles as predictive biomarkers
Go to Top